AbbVie
ABBV
#26
Rank
HK$3.110 T
Marketcap
HK$1,760
Share price
-1.15%
Change (1 day)
31.91%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Cash on Hand

Cash on Hand as of September 2025 : HK$44.14 Billion

According to AbbVie's latest financial reports the company has HK$44.14 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

AbbVie - Cash on Hand chart (from 2011 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31HK$43.12 B-56.91%
2023-12-31HK$100.09 B38.81%
2022-12-31HK$72.10 B-5.93%
2021-12-31HK$76.65 B16.61%
2020-12-31HK$65.73 B-78.86%
2019-12-31HK$310.93 B392.57%
2018-12-31HK$63.12 B-17.46%
2017-12-31HK$76.48 B53.55%
2016-12-31HK$49.80 B-23.56%
2015-12-31HK$65.16 B0.32%
2014-12-31HK$64.95 B-15.35%
2013-12-31HK$76.72 B24.11%
2012-12-31HK$61.82 B1118.97%
2011-12-31HK$5.07 B5948.41%
2010-12-31HK$83.85 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
HK$116.64 B 164.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$128.46 B 190.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$77.17 B 74.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$73.52 B 66.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$57.20 B 29.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$30.83 B-30.16%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$34.59 B-21.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
AstraZeneca
AZN
HK$63.69 B 44.28%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
HK$8.67 B-80.34%๐Ÿ‡บ๐Ÿ‡ธ USA